Abenovelab

Active

Private limited companyfounded 2022active for 4 yearsHostenstraat(Kok) 14, 8670 Koksijde, BelgiumKBO/BCE: BE 0780.558.109

Summary

Abenovelab has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €43,100 and a net result of €168,465. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 19% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

AbenovelabActiveChecked score 85/100

Risk analysis Report Compare

Activity

Specialist medical practice

NACE 86220

1 site

Size

≈ €400,000turnover 2025, estimated

Equity: €43,100
Profit: €168,465

Turnover estimated from the gross margin

Financial health

85 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Structure

2025 accounts 17 days early2 of 3 deeds summarised

Why 85raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 15-04-2026)Size: total assets €222,974Show the evidence

Checked score

Score 2025

85 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 27% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 44-56

equity 19.3% of total assets

Liquidity 20-49

short-term debt 79.3% · cash 10.6%

Profitability 100=

return on assets 75.6%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)

Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: < 0.1%▼ -0.1 percentage points vs 10-2025lowest value 12-2025: 0.1%▲ +0.1 percentage points vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.2%▲ +0.1 percentage points vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026highest value

Credit of up to €3,500 on 30-day terms is acceptable

Liquidity tight (current ratio 1.25, compared with 8.47 in 2024, below the usual 1.5; short-term debt: 79.3% and cash: 10.6% of total assets), and 80.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 20% on solvency, 3% on liquidity, 80% on profitability and 6% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

1 change of registered office in 24 months

Belgian Official Gazette

Figures for financial year 2025 (filed 15-04-2026)

NBB · annual accounts

Size: total assets €222,974

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 20643 sector peers (2025).

NBB · sector comparison

Position among 20643 sector peers

Solvency

better than 19%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 13-04-2026, 17 days ahead of the deadline.

NBB · 4 filings

Deviation from the deadline

2025

17 days early

2024

23 days early

2023

36 days early

2022

41 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 29 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 1 April (4 of the last 4 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end29-10-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

Searched since incorporation in 2022.

KBO publications · our coverage

13-04-2026 Annual accounts filedfinancial year 2025 · micro…
18-11-2025 Registered office · NameName change · Registered-office move…
07-04-2025 Annual accounts filedfinancial year 2024 · micro…

Key points

Caution: Equity fell in 2025from €407,648 to €43,100 ▼ 89.4% View
Caution: Among the weakest 20% on solvencysector median 63.0% · 20,643 companies 19.3% View
Positive: Always filed on timeaccounts within the deadline every year 4 years View

By topic

Financials

Financial year: 2025
Total assets: €222,974
Profit: €168,465
Solvency: 19.3%

Total assets▼ 52.0%

Net result

20222025

Go to Financials

Timeline

Events: 8
Since: 2023
Next accounts: by 30-04-2027

30-09-2024Highest result from 2022 to 2025
25-03-2024Annual accounts filed
04-10-2023Registered office

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Specialist medical practiceNACE 86220
Founded: 17-01-2022
Year ends: 30-09
Peppol: Reachable for e-invoices

Go to Company details

Key facts about Abenovelab

What is the company number of Abenovelab?: 0780.558.109. In Belgium the VAT number is the company number with BE in front: BE 0780.558.109.
Where is Abenovelab based?: The registered office is at Hostenstraat(Kok) 14, 8670 Koksijde.Company details
What does Abenovelab do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Abenovelab?: Private limited company (BV).
When was Abenovelab founded?: On 17-01-2022.
Is Abenovelab still active?: Yes, Abenovelab is an active enterprise in the KBO register.
What is the turnover of Abenovelab?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Abenovelab profitable?: In financial year 2025, Abenovelab made a profit of €168,465.
Where can I find the annual accounts of Abenovelab?: Abenovelab filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Abenovelab due?: By 30-04-2027, for financial year 2026.Timeline